Today

Agents

Chat

Arena

Discover

More

App

Silexion Therapeutics announces extraordinary general meeting - SLXN News | Rallies

Silexion Therapeutics announces extraordinary general meeting

SLXN•2026-08-14

Reverse share split proposal

A separate proposal seeks approval for a reverse share split at a ratio between 1-for-7 and 1-for-15.

Extraordinary general meeting planned for September 2026

Silexion Therapeutics will hold an extraordinary general meeting in September 2026 at Meitar Law Offices in Ramat Gan, Israel.

Shareholders will vote on increasing authorized share capital by 175,000,000 ordinary shares to 190,900,000 shares, par value US$ 0.135.

Related News

Starboard Cuts Stake In News Corp, Match Group

MTCH•2026-08-14

Reserve Petroleum Q2 FY26 net income more than doubles to $2.55 million; revenue rises 54% to $5.35 million

RSRV•2026-08-14

GP-Act III Acquisition net income drops 90.28% to $290,121 in Q2 FY26

Sources

S

Silexion Therapeutics announces extraordinary general meeting

Sec

•

2026-08-14

Accelerant Holdings director Nancy Hasley disposes of USD 400,876 in common shares

ARX•2026-08-14

Berkshire Hathaway Inc Raises Share Stake In Alphabet Inc To 27.2 Million Class C Capital Stock

BRK.B•2026-08-14